IP Library › Granted Patent US 9,034,386
Granted Patent B2
US 9,034,386 · App. 12/971,531 · Granted May 19, 2015

Decellularized adipose tissue

Inventor: Lauren E. Flynn (Kingston, CA)
Assignee: Queen's University at Kingston
C12N11/02A61L27/3604A61L27/3683A61L2430/40C12N5/0653C12N2533/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,034,386
App. No.
12/971,531
Granted
May 19, 2015
Kind
B2
Abstract

This invention provides a method for decellularizing adipose tissue, comprising subjecting the adipose tissue to one or more incubations in an enzymatic digestion solution containing one or more enzymes, and one or more solvent extractions, wherein decellularized adipose tissue comprising an extracellular matrix with well-preserved three-dimensional structure is obtained. The invention also provides a decellularized adipose tissue comprising an extracellular matrix with well-preserved three-dimensional architecture, and bioscaffolds, microcarrier beads, and coatings comprising the decellularized adipose tissue.

Claims (46)

1. A method for decellularizing adipose tissue, comprising: subjecting the adipose tissue to mechanical disruption including one or more freeze-thaw cycles, one or more incubations in an enzymatic digestion solution containing one or more enzymes, one or more polar solvent extractions, and one or more rinses in a rinsing buffer;

wherein decellularized adipose tissue comprising an extracellular matrix with well-preserved three-dimensional structure is obtained, the extracellular matrix including fibrous collagen and network-type collagen.

2. The method of claim 1 , further comprising one or more non-polar solvent extractions.

3. The method of claim 1 , further comprising at least a second step involving mechanical disruption.

4. The method of claim 1 , further comprising perfusing the enzymatic digestion solution containing one or more enzymes and/or the one or more polar solvents into the adipose tissue.

5. The method of claim 4 , further comprising perfusing the adipose tissue by cannulating an artery and/or a vein.

6. The method of claim 1 , comprising two or more rinses in a rinsing buffer.

7. The method of claim 1 , wherein subjecting the adipose tissue to mechanical disruption further includes agitation.

8. The method of claim 1 , wherein the one or more freeze-thaw cycles are carried out in a hypotonic solution.

9. The method of claim 1 , comprising

(i) subjecting the adipose tissue to one or more freeze-thaw cycles in a freezing buffer;

(ii) subjecting the adipose tissue to enzymatic digestion;

(iii) subjecting the adipose tissue to one or more polar solvent extractions;

(iv) washing the adipose tissue in rinsing buffer;

(v) subjecting the adipose tissue to enzymatic digestion;

(vi) washing the adipose tissue in rinsing buffer;

(vii) subjecting the adipose tissue to enzymatic digestion;

(viii) washing the adipose tissue in rinsing buffer;

(ix) subjecting the adipose tissue to polar solvent extraction; and

(x) washing the adipose tissue in rinsing buffer.

10. The method of claim 1 , wherein the decellularized adipose tissue is substantially devoid of intact adipose cells.

11. The method of claim 1 , comprising substantially removing immunogenic components of the adipose tissue.

12. The method of claim 1 , further comprising solubilizing the decellularized adipose tissue.

13. The method of claim 1 , wherein the extracellular matrix includes type IV collagen.

14. The method of claim 1 , wherein the extracellular matrix includes one or more of collagens type I to III, V, and VI.

15. The method of claim 1 , wherein the extracellular matrix includes laminin, fibronectin, or both.

16. The method of claim 1 , wherein the extracellular matrix includes one or more proteoglycan, glycoprotein, or glycosaminoglycan, or any combination thereof.

17. The method of claim 1 , wherein the extracellular matrix includes one or more growth factor.

18. The method of claim 1 , wherein the extracellular matrix includes elastic fibres and/or elastin.

19. The method for decellularizing adipose tissue of claim 1 , further comprising using the decellularized adipose tissue as a cell culture substrate.

20. The method of claim 19 , wherein the cell culture is for cell expansion and/or cell differentiation and/or for the production of bioproducts, including tissue and one or more proteins.

21. The method for decellularizing adipose tissue of claim 1 , further comprising using the decellularized adipose tissue as a bioscaffold.

22. The method of claim 21 , wherein the bioscaffold is for use in a surgical procedure.

23. The method of claim 22 , wherein the surgical procedure is general surgery, reconstructive surgery, cosmetic surgery, cardiac surgery, orthopaedic surgery, neurosurgery, or urological or gynaecological surgery.

24. The method of claim 21 , wherein the bioscaffold is used for wound healing applications.

25. The method of claim 21 , wherein the bioscaffold is used as a hemostatic agent.

26. The method of claim 21 , wherein the bioscaffold includes one or more additional materials.

27. The method of claim 26 , wherein the one or more additional materials are selected from other decellularized matrices, naturally-derived materials, synthetic materials, a pharmaceutical composition, a hormone, a growth factor, and any combination thereof.

28. The method of claim 21 , wherein the bioscaffold is autologous or allogenic.

29. The method of claim 21 , wherein the bioscaffold is xenogenic.

30. The method for decellularizing adipose tissue of claim 1 , further comprising using the decellularized adipose tissue as a coating material.

31. The method for decellularizing adipose tissue of claim 1 , further comprising using the decellularized adipose tissue in a microcarrier bead.

32. The method of claim 31 , wherein the microcarrier bead is used as a cell and/or drug and/or growth factor delivery vehicle.

33. The method of claim 31 , wherein the microcarrier bead is used as a small volume-bulking agent in cosmetic or reconstructive surgery.

34. The method of claim 31 , wherein the microcarrier bead is used in fabrication of a composite bioscaffold with decellularized adipose tissue.

35. The method for decellularizing adipose tissue of claim 1 , further comprising using the decellularized adipose tissue as a particle.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2022
From: FLYNN, LAUREN E.
To: THE UNIVERSITY OF WESTERN ONTARIO
Reel/Frame 061562/0291 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2022
From: QUEEN'S UNIVERSITY AT KINGSTON
To: FLYNN, LAUREN E.
Reel/Frame 061463/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2011
From: FLYNN, LAUREN E
To: QUEEN'S UNIVERSITY AT KINGSTON
Reel/Frame 026012/0001 →
Continuity (2)
Provisional Application 61287236 · Dec 17, 2009
Related Publication 20110151011A1 · Jun 23, 2011